Numerous people throughout the UK are experiencing a puzzling and severe skin condition that has left the medical profession baffled. Sufferers experience their skin badly inflamed, cracked and flaking, commonly affecting large areas of their body, yet many doctors struggle to diagnose or treat the condition. The phenomenon, known as topical steroid withdrawal (TSW) or red skin syndrome, has created considerable interest on social media, with clips featuring patients’ experiences receiving more than a billion views on TikTok alone. Although it affects a growing number of people, TSW remains so poorly understood that some doctors and dermatologists doubt whether it exists at all. Now, for the very first time, researchers across the UK are commencing a large-scale study to determine what is responsible for these unexplained symptoms and how some people come to develop the condition while others remain unaffected.
The Mysterious Condition Spreading Across the UK
Bethany Gamble’s case exemplifies the devastating impact of topical steroid withdrawal on patients’ wellbeing. The 21-year-old from Birmingham had handled her eczema well with steroid creams since childhood, but at eighteen, her condition worsened considerably. Her skin became severely inflamed and reddened, splitting and weeping whilst the itching became what she describes as “bone deep”. Within two years, the pain had become so acute that she was confined to her bed, needing constant care from her mother. Most distressing of all, Bethany found herself repeatedly dismissed by healthcare providers who blamed her symptoms on standard eczema and continued prescribing the very treatments she suspected were triggering her suffering.
The healthcare sector continues to disagree on how to address TSW, with deep divisions about its core nature. Some experts regard it as a severe allergic response to the steroid-based creams that serve as the primary treatment for eczema across the NHS. Others argue it amounts to a acute flare-up of existing skin conditions rather than a distinct syndrome, whilst a handful are sceptical of its existence. This clinical uncertainty has placed patients like Bethany stuck in a diagnostic limbo, struggling to access proper treatment. The absence of agreement has led Professor Sara Brown at the University of Edinburgh to set up the first major UK research project examining TSW, funded by the National Eczema Society.
- Symptoms include significant swelling, skin fissuring and persistent pruritus throughout the body
- Patients report “elephant skin” thickening and extreme shedding of dead skin cells
- Medical professionals commonly disregard TSW as standard eczema or refuse to acknowledge it
- The condition may prove so debilitating that sufferers become unable to perform daily activities
Living with Topical Steroid Withdrawal
From Mild Eczema to Disabling Symptoms
For numerous sufferers, withdrawal from topical steroids constitutes a severe decline from a previously stable skin condition. What begins as occasional itching in areas of skin fold can rapidly escalate into a full-body inflammatory response that renders patients incapable of functioning. The transition often occurs abruptly, unexpectedly, converting a manageable chronic condition into an severe medical emergency. Patients report their skin turning impossibly hot, inflamed and red, with significant cracking and oozing that requires ongoing care. The physical toll is worsened by exhaustion, as the persistent itching prevents sleep and recovery, establishing a vicious cycle of decline.
The rate at which TSW progresses takes many sufferers off guard. Those who have lived with eczema for years, sometimes decades, are unprepared for the intensity of symptoms that emerge when their condition suddenly worsens. Everyday tasks become overwhelming difficulties: showering becomes agonising, dressing demands help, and preserving hygiene demands considerable exertion. Some patients report feeling as though their skin is under assault from within, with inflammation moving through their body in patterns that differ markedly to their earlier flare-ups. This marked shift often drives sufferers to pursue immediate medical attention, only to face disbelief from healthcare professionals.
The Quest for Recognition
Perhaps the most distressing aspect of topical steroid withdrawal is the medical gaslighting that commonly occurs with it. Patients experiencing serious, unexplained health issues are routinely told they merely suffer from eczema worsening, despite their insistence that this is essentially distinct from anything they’ve encountered previously. Doctors frequently react by prescribing stronger steroids or increased doses, possibly exacerbating the very condition patients suspect the topical treatments triggered. This pattern of rejection leaves sufferers experiencing abandonment by the healthcare system, forced to navigate their illness alone whilst being told their lived experience is invalid. Many patients report experiencing repeated invalidation, their worries disregarded as emotional or psychological in nature rather than genuine physiological symptoms.
The lack of medical consensus has established a significant divide between what patients report and professional recognition. Without established diagnostic standards or defined treatment approaches, general practitioners and skin specialists struggle to identify TSW or offer appropriate support. Some practitioners remain entirely unconvinced the condition exists, treating all severe presentations as typical eczema or recognised skin disorders. This professional uncertainty translates into diagnostic delays, inappropriate treatment and profound psychological distress for people experiencing physical symptoms. The increased prominence of TSW on online platforms has drawn attention to this diagnostic gap, prompting researchers to examine the experiences reported by vast numbers of individuals, even as the healthcare profession continues to disagree on how to respond.
- Symptoms can emerge abruptly in individuals with formerly controlled eczema treated by steroid creams
- Patients frequently encounter disbelief from medical practitioners who attribute deterioration to typical eczema exacerbations
- Healthcare providers continue to disagree on whether TSW is a genuine condition or severe eczema exacerbation
- Lack of diagnostic criteria means numerous patients find it difficult to obtain suitable care and support
- Social media has amplified patient voices, with TSW hashtags accumulating more than one billion views worldwide
Racial Inequities in Assessment and Clinical Management
The diagnostic challenges surrounding topical steroid withdrawal become increasingly evident amongst those with darker complexions, where symptoms can be substantially more challenging to detect visually. Erythema and inflammatory responses, the defining features of TSW in those with lighter complexions, manifest differently across different ethnic groups, yet many assessment protocols remain focused on how the condition appears in white patients. This disparity means that individuals from Black, Asian and minority ethnic backgrounds experiencing TSW frequently encounter significantly extended timeframes in recognition and validation. Medical staff trained primarily on manifestations in lighter-skinned individuals may miss or misread the characteristic signs, causing further misdiagnosis and unsuitable therapeutic suggestions that can intensify distress.
Research into TSW has historically overlooked the experiences of people with darker complexions, sustaining a pattern where their condition goes under-documented and under-studied. The online discussions shaping TSW discourse have been largely shaped by voices with lighter skin, risking distortion of medical understanding and community understanding. As Professor Sara Brown’s pioneering British research progresses, guaranteeing inclusive participation amongst participants will be essential to developing truly inclusive diagnostic frameworks and therapeutic strategies. Without intentional action to prioritise the perspectives of diverse populations, treatment inequalities in TSW identification and care threaten to increase, leaving vulnerable populations without sufficient assistance or solutions.
| Skin Tone | TSW Appearance |
|---|---|
| Light/Fair | Bright red inflammation, visible flushing and erythema across affected areas |
| Medium/Olive | Darker red or brownish discolouration with less pronounced visible redness |
| Dark/Deep | Purple-toned or ashen discolouration, with inflammation appearing as hyperpigmentation or hypopigmentation |
| Very Dark | Subtle changes in skin texture and tone, with inflammation manifesting as dark patches or loss of pigmentation |
Emerging Research and Care Solutions Developing
First Major UK Study In Progress
Professor Sara Brown’s pioneering research at the University of Edinburgh constitutes a significant milestone for TSW sufferers seeking validation and comprehension. With backing from the National Eczema Society, the study has enrolled many participants across the UK to investigate the biological mechanisms underlying topical steroid withdrawal. By assessing symptoms, saliva samples and skin biopsies, researchers hope to identify why some people experience TSW whilst others on identical steroid regimens do not. This scientific scrutiny marks a notable change from dismissal to serious investigation.
The investigative group partnering with Dr Alice Burleigh from advocacy group for patients Scratch That, brings both medical knowledge and personal experience to the research. Their partnership approach acknowledges that patients themselves hold vital knowledge into their conditions. Professor Brown has identified patterns in TSW that cannot be accounted for by standard eczema knowledge, including characteristic “elephant skin” thickening, severe shedding and clearly defined inflammatory patches. The study results could fundamentally reshape how healthcare practitioners approach diagnosis and management of this disabling illness.
Treatment Options and Associated Limitations
At present, treatment options for TSW are quite limited and frequently inadequate. Many healthcare professionals continue prescribing topical steroids despite clear evidence suggesting they may exacerbate symptoms in those predisposed. Some patients note transient relief from moisturisers, antihistamines and systemic drugs, though outcomes differ significantly. Dermatologists continue to disagree on best treatment approaches, with some supporting total steroid discontinuation whilst others recommend gradual tapering. This lack of consensus forces patients to navigate their therapeutic pathways mostly in isolation, relying heavily on peer support networks and web-based forums for guidance.
Psychological assistance with specialist dermatological care offer potential benefits, yet access is inconsistent across the NHS. Some patients have explored alternative approaches including changes to diet, environmental controls and holistic therapies, though scientific evidence supporting these interventions is limited. The absence of established clinical protocols means treatment decisions frequently rely upon individual dermatologist experience and patient preference rather than evidence-based guidelines. Until robust research produces definitive answers, TSW sufferers frequently describe experiencing abandonment by conventional medicine.
- Emollient creams and hydrating products to support skin barrier function and reduce water loss
- Antihistamines to control pruritus and associated sleep disruption during flare-ups
- Oral corticosteroids or immunosuppressants for severe cases under specialist supervision
- Psychological counselling to tackle emotional distress and worry related to prolonged skin suffering
Testimonies of Aspiration and Perseverance
Despite the lack of clarity surrounding TSW and the often dismissive perspectives from medical practitioners, patients are drawing strength in shared community and collective experience. Online support networks have proven vital for those struggling with the condition, providing validation and practical advice when conventional medicine has let them down. Many sufferers recount the moment they discovered the TSW hashtag as transformative—finally connecting with others with the same symptoms and recognising they were not isolated in their experience. This unified voice has been powerful enough to spark the initial serious research initiatives, showing that patient advocacy can drive medical progress even when institutional structures stay unconvinced.
Bethany Gamble and others like her are resolved to increase visibility and advocate for proper recognition of TSW within the medical community. Their willingness to discuss intimate experiences of their challenges on social media has made discussions more commonplace around a illness that many doctors still refuse to acknowledge. These people are not sitting idly for answers; they are engaging in clinical trials, documenting their symptoms thoroughly, and insisting that their accounts be given proper consideration. Their fortitude in the midst of ongoing pain and medical gaslighting offers hope that answers may finally be within grasp, and that future patients will receive the recognition and support they critically depend upon.
- Community-driven research projects are filling gaps overlooked by traditional medical institutions and accelerating understanding of TSW
- Digital support networks provide emotional support, practical coping strategies, and mutual recognition for isolated sufferers globally
- Campaign work are gradually shifting clinical attitudes, prompting dermatologists to examine rather than dismiss individual accounts
